
|Articles|February 11, 2022
Inherited Mutations in BRCA Genes May Affect Endometrial Cancer Risk
The risks for breast, ovarian, prostate and pancreatic cancers are elevated among people with inherited BRCA1 and BRCA2 mutations.
Advertisement
The risks for breast, ovarian, prostate and pancreatic cancers are elevated among people with inherited BRCA1 and BRCA2 mutations.
A new Dutch study shows that women with a BRCA1 mutation also have an increased risk of endometrial cancer, while women with a BRCA2 mutation have a risk similar to those without a mutation.
Additionally, people with a BRCA mutation in this study were more likely to be diagnosed with an aggressive form of endometrial cancer associated with poor outcomes. Read more about this study in our XRAY review on the topic.
Advertisement
Related to this article

Bravnetsa is the first radioligand therapy approved through the FDA's abbreviated pathway, adding an option for adults with SSTR-positive GEP-NETs.

The investigational drug, first developed for brain cancer, is being tested to see whether it can make resistant tumors respond to treatment again.

Cancer research is increasingly looking beyond the tumor to understand the whole body, immune system and patient experience.

AI is becoming a growing part of cancer care. Learn how doctors are using it to navigate complex treatment decisions and support patients.

In patients with advanced ROS1-positive lung cancer who had not previously received a ROS1-targeted drug, Jideytro also shrank tumors that had spread to the brain in all 10 evaluable patients.

An estimated 70% of patients with stage 3 lung cancer do not see their tumors respond to standard treatment. An expert explains why, and what a new approach aims to change.

Living with stage IV kidney cancer for 10 years, one survivor shares how he manages scanxiety, uncertainty and the waiting between scans.
Advertisement
Advertisement
Trending on CURE
1
The Growing Role of AI in Cancer Care
2
Blood Cancer Treatments in the FDA Pipeline: What Could Come Next
3
3 More Lung Cancer Breakthroughs From WCLC 2026
4
Why Some Stage 3 Lung Cancers Don't Respond to Treatment, and What Researchers Are Trying Next
5

